Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Do you have uveal melanoma (melanoma in the eye) that is HLA-A*02:01 positive, or do you have cutaneous melanoma (skin melanoma)?

This trial treats two types of melanoma differently. If you have uveal melanoma, you must carry the HLA-A*02:01 genetic marker. If you have cutaneous (skin) melanoma, you do not need this marker. This determines which type of melanoma you're eligible for.

Show original medical criteria

HLA-A*02:01 is a genetic marker required for uveal melanoma patients; cutaneous melanoma patients do not need this marker

This is informational only — not medical advice. Always discuss eligibility with your oncologist.